DATSCAN
Google image searchProduct monograph
Active ingredient
ioflupane (123i), 74 MBq/ML
DIN: 02470624
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-DOSE VIALS
Schedule: Schedule C
Company: GE HEALTHCARE CANADA INC
Date: 15-NOV-2018
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09A — CENTRAL NERVOUS SYSTEM (ATC, ATC/DDD)
- V09AB — Iodine (123I) compounds (ATC, ATC/DDD)
- V09AB03 — IODINE IOFLUPANE 123 I (ATC/DDD)
